GILD - Conference and earnings call announcements

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: BofA Securities Health Care Conference on Tuesday, May 12 at 2:20 PM Pacific Time RBC Capital Markets Global Healthcare Conference on Tuesday, May 19 at 11:00 AM Eastern Time Bernstein Annual Strategic Decisions Conference on Thursday, May 28 at 11:00 AM Eastern Time Goldman Sachs Annual Global Healthcare Conference on Tuesday, June 9 at 1:20 PM Eastern Time The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: TD Cowen Annual Health Care Conference on Tuesday, March 3 at 11:10 AM Eastern Time Leerink Partners Global Healthcare Conference on Tuesday, March 10 at 11:20 AM Eastern Time Barclays Annual Global Healthcare Conference on Wednesday, March 11 at 11:00 AM Eastern Time The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthro

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conference: J.P. Morgan Healthcare Conference on Monday, January 12, 2026 beginning at 11:15 a.m. Pacific Time The live webcast can be accessed at investors.gilead.com and the replay will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, i

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: UBS Global Healthcare Conference on Monday, November 10 at 11:00 AM Eastern Time Jefferies Global Healthcare Conference in London on Wednesday, November 19 at 2:00 PM Greenwich Mean Time Citi's Global Healthcare Conference on Tuesday, December 2 at 11:15 AM Eastern Time Annual Evercore Healthcare Conference on Wednesday, December 3 at 10:50 AM Eastern Time The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilea

- Late-Breaking Real-World Experience of People Switching from Obeticholic Acid to Livdelzi® to be Presented at The Liver Meeting® 2025 - - New Three-Year Interim Data Demonstrates Livdelzi® May Help Stabilize or Improve Liver Health in PBC Patients - Gilead Sciences, Inc. (NASDAQ:GILD) will present new research that reinforces its commitment to advancing innovation for people living with liver disease at The Liver Meeting® 2025, hosted by the American Association for the Study of Liver Diseases (AASLD), November 7-11 in Washington, D.C. Key findings from more than 35 accepted abstracts across PBC and viral hepatitis will include late-breaking data and three oral presentations. Primar

– Global Initiative Seeks to Empower Individuals Navigating HIV Care Journey – Gilead Sciences, Inc. (NASDAQ:GILD) today announced the launch of Choose U™, a new campaign that spotlights the multifaceted experiences of people living with HIV globally. The timing of the campaign launch coincides with the convening of the 2025 United States Conference on HIV/AIDS (USCHA) taking place September 4-7 in Washington DC, which will center on the theme of aging with HIV. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250902021598/en/ Co-created with community representatives from around the world, Choose U is comprised of inspiring exa

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: Cantor Global Healthcare Conference on Wednesday, September 3 at 11:30 AM Eastern Time Wells Fargo Healthcare Conference on Thursday, September 4 at 11:00 AM Eastern Time Morgan Stanley Annual Global Healthcare Conference on Tuesday, September 9 at 10:45 AM Eastern Time Baird Global Healthcare Conference on Wednesday, September 10 at 11:25 AM Eastern Time The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: BofA Securities Health Care Conference on Tuesday, May 13 at 11:20 AM Pacific Time RBC Capital Markets Global Healthcare Conference on Wednesday, May 21 at 11:30 AM Eastern Time Bernstein Annual Strategic Decisions Conference on Thursday, May 29 at 2:30 PM Eastern Time Jefferies Global Healthcare Conference on Wednesday, June 4 at 11:05 AM Eastern Time Goldman Sachs Annual Global Healthcare Conference on Tuesday, June 10 at 11:20 AM Eastern Time The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays wi

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: TD Cowen Annual Health Care Conference on Tuesday, March 4 at 11:10 AM Eastern Time Leerink Partners Global Healthcare Conference on Tuesday, March 11 at 10:40 AM Eastern Time The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all peopl

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conference: J.P. Morgan Healthcare Conference on Monday, January 13, 2025 beginning at 11:15 a.m. Pacific Time The live webcast can be accessed at investors.gilead.com and the replay will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening disease

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: Jefferies London Healthcare Conference on Wednesday, November 20 at 9:30 AM Greenwich Mean Time Piper Sandler Annual Healthcare Conference on Tuesday, December 3 at 11:00 AM Eastern Time Annual Evercore ISI HealthCONx Conference on Wednesday, December 4 at 11:40 AM Eastern Time The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakth

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: Wells Fargo Healthcare Conference on Wednesday, September 4 at 11:00 AM Eastern Time Morgan Stanley Annual Global Healthcare Conference on Thursday, September 5 at 12:20 PM Eastern Time Baird Global Healthcare Conference on Tuesday, September 10 at 10:50 AM Eastern Time The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakth

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: BofA Securities Health Care Conference on Tuesday, May 14 at 11:20am Pacific Time RBCCM Global Healthcare Conference on Wednesday, May 15 at 10:30am Eastern Time Jefferies Global Healthcare Conference on Wednesday, June 5 at 11:00am Eastern Time Goldman Sachs Annual Global Healthcare Conference on Wednesday, June 12 at 1:20pm Eastern Time The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, In

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: TD Cowen Annual Health Care Conference on Tuesday, March 5 at 12:50pm Eastern Time Leerink Partners Global Biopharma Conference on Tuesday, March 12 at 10:00am Eastern Time Barclays Annual Global Healthcare Conference on Wednesday, March 13 at 11:15am Eastern Time The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs i

– Investment Reinforces Companies' Conviction in TIGIT Pathway and Provides Opportunity to Accelerate the Anti-TIGIT Program – – Additional Equity Investment of $320M, Raising Gilead's Ownership Stake in Arcus to 33% – – Amendment Provides Gilead with One Additional Seat on the Arcus Board – Gilead Sciences, Inc. (NASDAQ:GILD) and Arcus Biosciences, Inc. (NYSE:RCUS) today announced an amendment to their collaboration agreement and a separate equity investment by Gilead of $320 million in Arcus common stock at $21.00 per share. The equity investment and collaboration amendment enable accelerated growth of the companies' joint development programs that span multiple indications. Additio

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conference: J.P. Morgan Healthcare Conference on Monday, January 8, 2024 beginning at 10:30 a.m. Pacific Time The live webcast can be accessed at the company's investors page at investors.gilead.com. The replay will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and trea

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: Jefferies London Healthcare Conference on Wednesday, November 15 at 9:00am Greenwich Mean Time Evercore ISI HealthCONx Conference on Tuesday, November 28 at 1:20pm Eastern Time Piper Sandler Healthcare Conference on Wednesday, November 29 at 9:00am Eastern Time The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in m

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: Wells Fargo Healthcare Conference Wednesday, September 6 at 11:00 am ET Morgan Stanley Annual Global Healthcare Conference on Tuesday, September 12 at 11:30 am ET The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The comp

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conference: Jefferies Healthcare Conference on Wednesday, June 7 at 11:00am ET The live webcast can be accessed at the company's investors page at investors.gilead.com. The replay will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, in

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: BofA Securities Health Care Conference on Tuesday, May 9 at 2:20pm ET RBC Capital Markets Global Healthcare Conference on Tuesday, May 16 at 11:00am ET Goldman Sachs Global Healthcare Conference on Monday, June 12 at 1:40pm ET The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, wi

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: SVB Securities Global Biopharma Conference on Tuesday, February 14 at 11:20 AM Eastern Time Cowen Annual Health Care Conference on Tuesday, March 7 at 11:10 AM Eastern Time Barclays Global Healthcare Conference on Wednesday, March 15 at 10:15 AM Eastern Time The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for m

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conference: J.P. Morgan Healthcare Conference on Monday, January 9, 2023 beginning at 10:30 a.m. Pacific Time The live webcast can be accessed at the company's investors page at investors.gilead.com. The replay will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat li

– 35-45% Reduction in Risk of Progression or Death and a Doubling of mPFS Were Observed in the Domvanalimab-Containing Study Arms, Compared to Zimberelimab Monotherapy in First-Line, PD-L1-High NSCLC – – With Median Follow-Up of Approximately 12 Months, Both Domvanalimab-Containing Study Arms Also Improved ORR and Six-Month Landmark PFS Compared to Zimberelimab Monotherapy – – Detailed Results Will Be Presented on December 20 at 3pm ET / 12pm PT during the ASCO Monthly Plenary Series – Gilead Sciences, Inc. (NASDAQ:GILD) and Arcus Biosciences, Inc. (NYSE:RCUS) today announced positive results from the fourth interim analysis of the ARC-7 study in patients with first-line, metastatic non-

– DJSI World Highlights the Most Sustainable Companies Around the World Based on Corporate Sustainability Assessment – – Ranking Reflects Gilead's Ongoing Commitment to Corporate Responsibility – Gilead Sciences, Inc. (NASDAQ:GILD) today announced the company has once again been recognized as one of the most sustainable pharmaceutical companies according to the Dow Jones Sustainability World Index (DJSI World). This ranking is based on an in-depth analysis of Gilead's sustainability performance and highlights the company's longstanding sustainable business practices and transparency on environmental, social and governance (ESG) issues. "We are very pleased to receive this recognition onc

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: Evercore ISI Annual HealthCONx Conference on Tuesday, November 29 at 1:00 PM Eastern Time Piper Sandler Healthcare Conference on Wednesday, November 30 at 11:30 AM Eastern Time Nasdaq Investor Conference on Wednesday, December 7 at 1:00 PM Greenwich Mean Time The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: Wells Fargo Healthcare Conference on Thursday, September 8 at 10:25am Eastern Time Morgan Stanley Annual Global Healthcare Conference on Tuesday, September 13 at 10:35am Eastern Time Baird Global Healthcare Conference on Wednesday, September 14 at 9:40am Eastern Time The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medic

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: Bank of America Healthcare Conference on Tuesday, May 10 at 5:00pm ET Bernstein's Annual Strategic Decisions Conference on Thursday, June 2 at 4:30pm ET Jefferies Global Healthcare Conference on Wednesday, June 8 at 11:00am ET Goldman Sachs Global Healthcare Conference on Wednesday, June 15 at 2:20pm ET The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursu

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: SVB Leerink Annual Global Healthcare Conference on Wednesday, February 16 at 2:20pm ET Raymond James Annual Institutional Investors Conference on Tuesday, March 8 at 1:05pm ET Cowen Annual Health Care Conference on Wednesday, March 9 at 10:30am ET The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than th

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conference: J.P. Morgan Healthcare Conference and Q&A Breakout on Monday, January 10 beginning at 11:15 a.m. Eastern Time The live webcast can be accessed at the company's investors page at investors.gilead.com. The replay will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conference: Evercore ISI Annual HealthCONx Conference on Thursday, December 2 at 2:40pm ET The live webcast can be accessed at the company's investors page at investors.gilead.com. The replay will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening dise

NEW YORK and AMSTERDAM, Nov. 12, 2021 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI"), the world's leading index provider, today announced the results of the annual Dow Jones Sustainability Indices (DJSI) rebalancing and reconstitution. The DJSI are float-adjusted market capitalization weighted indices that measure the performance of companies selected using environmental, social and governance (ESG) criteria. The DJSI, including the Dow Jones Sustainability World Index (DJSI World), were launched in 1999 as the pioneering series of global sustainability benchmarks available in the market. The index family is comprised of global, regional and country benchmarks. As a result of this year's

– Double-Blind Placebo-Controlled Study Evaluated the Efficacy of Early Use of Veklury IV in Non-Hospitalized Patients – – Late-breaking Data to be Presented at IDWeek 2021 – Gilead Sciences, Inc. (NASDAQ:GILD) today announced positive results from a Phase 3 randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of a three-day course of Veklury® (remdesivir) for intravenous (IV) use for the treatment of COVID-19 in non-hospitalized patients at high risk for disease progression. This late-breaking data will be presented at the IDWeek 2021 virtual conference. In an analysis of 562 participants randomly assigned in a 1:1 ratio to receive Veklury or placebo, V

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conference: Morgan Stanley Annual Global Healthcare Conference on Wednesday, September 15 at 12:30pm ET The live webcast can be accessed at the company's investors page at investors.gilead.com. The replay will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-thr

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: Cowen Annual Virtual Oncology Innovation Summit on Friday, May 21 at 12:00pm ET Jefferies Virtual Healthcare Conference on Tuesday, June 1 at 1:30pm ET Bernstein Annual Strategic Decisions Conference on Wednesday, June 2 at 4:30pm ET Goldman Sachs Annual Global Healthcare Conference on Wednesday, June 9 at 2:10pm ET The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical c

Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its executives will be speaking at the following investor conferences: BofA Securities 2021 Virtual Health Care Conference on Thursday, May 13, 2021 at 2:00 p.m. ET RBC Capital Markets 2021 Global Health Care Conference on Wednesday, May 19, 2021 at 10:20 a.m. ET The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier w

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 1:40 p.m. EST Cowen Annual Health Care Conference on Thursday, March 4, 2021 at 12:10 p.m. EST The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 14 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal o

FOSTER CITY, Calif. & WASHINGTON--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and the Human Rights Campaign (HRC), the nation’s largest lesbian, gay, bisexual, transgender and queer (LGBTQ+) civil rights organization, today announced that Gilead will provide a $3.2 million grant over two years to support communities disproportionately impacted by the HIV epidemic in the United States, particularly communities of color. Gilead will directly fund the efforts of the HRC Foundation – HRC’s educational arm – aimed at ending the HIV epidemic, as well as fund the organization’s Transgender Justice Initiative. This innovative initiative builds on core strengths of each organizati

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Daniel O’Day, Gilead’s Chairman and Chief Executive Officer, will provide an overview of the company at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11 at 12:40 p.m. Pacific Time. The live webcast can be accessed at the company’s Investors page at http://investors.gilead.com. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation. About Gilead Sciences Gile

-- Gilead will Not Advance Jyseleca for the Treatment of Rheumatoid Arthritis (RA) in the U.S. Following FDA Type A Meeting -- -- Galapagos to Assume Sole Responsibility in Europe for Jyseleca in RA and Ulcerative Colitis (UC) Plus Future Indications; Gilead to Receive Royalties on European Sales Starting in 2024 -- -- Galapagos to Assume Responsibility for Majority of Ongoing Clinical Trials -- -- Gilead will Pay Galapagos €160 million to Support Ongoing Development and Accelerated Commercial Buildout in EU -- Galapagos webcast presentation tomorrow, 16 December 2020, at 14:00 CET / 8 AM ET, www.glpg.com +32 2 793 38 47, code 7689939 Foster City, Calif., and Mechelen, Belgi